Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Head and Neck
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 26 Sep 2017 Status changed from active, no longer recruiting to discontinued.
- 11 Jan 2007 Status changed from recruiting to in progress
- 20 Sep 2005 New trial record.